Renea A. Taylor
Papers
1
Total Citations
67
H-Index
1
About
Renea A. Taylor is a pioneering cancer biologist whose work has reshaped our understanding of prostate cancer progression and treatment. Her research centers on the tumor microenvironment, cancer stem cells, and the development of physiologically relevant preclinical models. Taylor’s major contributions include establishing patient-derived xenograft (PDX) models that faithfully recapitulate human prostate cancer, enabling more accurate drug testing. Her landmark 2021 study, “High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids” (67 citations), introduced a scalable platform for screening therapeutics in three-dimensional cultures derived from PDXs, bridging a critical gap between basic research and clinical application. This work addresses the longstanding scarcity of robust prostate cancer preclinical models, offering a powerful tool for identifying new treatments. Taylor’s impact is reflected in her highly cited publications and her role in advancing personalized medicine approaches for prostate cancer. Her innovative organoid and imaging assays have been widely adopted, accelerating drug discovery and deepening our knowledge of tumor biology. For students and researchers, Taylor exemplifies how creative model development can drive translational breakthroughs in oncology.
Research Focus
Key Achievements
Top Papers
- 1